Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom
- PMID: 33498716
- PMCID: PMC7912640
- DOI: 10.3390/antibiotics10020110
Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom
Abstract
Since first identified in late 2019, the acute respiratory syndrome coronavirus (SARS-CoV2) and the resulting coronavirus disease (COVID-19) pandemic has overwhelmed healthcare systems worldwide, often diverting key resources in a bid to meet unprecedented challenges. To measure its impact on national antimicrobial stewardship (AMS) activities, a questionnaire was designed and disseminated to antimicrobialstewardship leads in the United Kingdom (UK). Most respondents reported a reduction in AMS activity with 64% (61/95) reporting that COVID-19 had a negative impact on routine AMS activities. Activities reported to have been negatively affected by the pandemic include audit, quality improvement initiatives, education, AMS meetings, and multidisciplinary working including ward rounds. However, positive outcomes were also identified, with technology being increasingly used as a tool to facilitate stewardship e.g., virtual meetings and ward rounds and increased the acceptance of using procalcitonin tests to distinguish between viral and bacterial infections. The COVID-19 pandemic has had a significant impact on the AMS activities undertaken across the UK. The long-term impact of the reduced AMS activities on incidence of AMR are not yet known. The legacy of innovation, use of technology, and increased collaboration from the pandemic could strengthen AMS in the post-pandemic era and presents opportunities for further development of AMS.
Keywords: AMR; AMS; COVID-19; SARS-CoV-2; antimicrobial resistance; antimicrobial stewardship; coronavirus.
Conflict of interest statement
The authors declare no conflict of interest. The organizations the authors of this manuscript have their substantive infection lead roles in are listed: D.A.-O. (Public Health England); F.K. (NHS Lanarkshire, Scotland); S.H. (Chelsea and Westminster Hospital NHS Trust); J.U.(Great Western Hospitals NHS Foundation Trust); M.L. (Royal Free London NHS Foundation Trust); T.Y. (St George’s University Hospitals NHS Foundation Trust); A.C. (Alison Cockburn) (NHS Lothian, Scotland); A.S. (Portsmouth Hospitals University NHS Trust); R.P. (Dartford And Gravesham NHS Trust); C.G. (Western Trust, Northern Ireland); A.C. (Aneeka Chavda) (Imperial College Healthcare NHS Trust); T.V. (West Hertfordshire Hospitals NHS Trust); C.P. (Aneurin Bevan University Health Board, Wales); N.R. (Public Health Wales); A.B. (Queens University, Belfast).
Figures
References
-
- Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
-
- Mazdeyasna H., Nori P., Patel P., Doll M., Godbout E., Lee K., Noda A.J., Bearman G., Stevens M.P. Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs. Curr. Infect. Dis. Rep. 2020;22:1–6. doi: 10.1007/s11908-020-00734-x. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
